NCT03507608View on ClinicalTrials.gov

Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

May 10, 2019

Primary Completion Date

September 30, 2024

Study Completion Date

July 3, 2025

Conditions
Prostate Cancer
Interventions
DRUG

Flutamide

50mg flutamide prior to brachytherapy and prostatic biopsy

OTHER

Placebo

placebo prior to brachytherapy and prostatic biopsy

Trial Locations (1)

21287

SKCCC at Johns Hopkins, Baltimore

All Listed Sponsors
collaborator

Patrick C. Walsh Fund

UNKNOWN

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT03507608 - Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression | Biotech Hunter | Biotech Hunter